Heating Up

The Boston Globe notes a recent spike in biotech merger and acquisitions. The deals going through at Inverness, Biogen, and Takeda follow an 18-month-long lull. "When you've had a cycle of fear and now we're seeing real signs that growth is coming," says Kevin Gorman from Putnam Associates, "if you can pick up an asset that fits your strategy, and you can pick it up at a decent price, why not?"

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.